- Home
- TNGX vs BLX Comparison
TNGX vs BLX Comparison
Compare TNGX & BLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | BLX |
|---|---|---|
| Founded | 2014 | 1977 |
| Country | United States | Panama |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TNGX | BLX |
|---|---|---|
| Price | $8.76 | $44.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 137.2K |
| Earning Date | 11-04-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 5.63% |
| EPS Growth | N/A | ★ 9.67 |
| EPS | N/A | ★ 6.00 |
| Revenue | $66,501,000.00 | ★ $308,426,000.00 |
| Revenue This Year | $52.80 | $18.35 |
| Revenue Next Year | N/A | $6.56 |
| P/E Ratio | ★ N/A | $7.40 |
| Revenue Growth | ★ 53.29 | 10.24 |
| 52 Week Low | $1.03 | $31.14 |
| 52 Week High | $11.20 | $48.38 |
Technical Indicators
Market Signals| Indicator | TNGX | BLX |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 50.26 |
| Support Level | $8.30 | $43.26 |
| Resistance Level | $8.82 | $44.80 |
| Average True Range (ATR) | 0.54 | 0.73 |
| MACD | -0.10 | -0.03 |
| Stochastic Oscillator | 25.56 | 49.40 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.